SQZ
Income statement / Annual
Last year (2022), SQZ Biotechnologies Company's total revenue was $21.03 M,
a decrease of 22.40% from the previous year.
In 2022, SQZ Biotechnologies Company's net income was -$78.24 M.
See SQZ Biotechnologies Company’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$21.03 M
|
$27.10 M
|
$21.00 M
|
$19.32 M
|
$12.67 M
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$21.03 M |
$27.10 M |
$21.00 M |
$19.32 M |
$12.67 M |
| Gross Profit Ratio |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$70.98 M
|
$70.15 M
|
$51.55 M
|
$36.10 M
|
$24.38 M
|
| General & Administrative
Expenses |
$26.32 M
|
$25.72 M
|
$20.51 M
|
$18.27 M
|
$8.69 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$26.32 M
|
$25.72 M
|
$20.51 M
|
$18.27 M
|
$8.69 M
|
| Other Expenses |
-$449,000.00 |
-$8,000.00 |
-$13,000.00 |
-$791,000.00 |
-$1.13 M |
| Operating Expenses |
$96.85 M |
$95.87 M |
$72.06 M |
$53.58 M |
$31.94 M |
| Cost And Expenses |
$96.85 M |
$95.87 M |
$72.06 M |
$53.58 M |
$33.07 M |
| Interest Income |
$1.22 M |
$36,000.00 |
$550,000.00 |
$2.07 M |
$978,000.00 |
| Interest Expense |
$9.72 M |
$0.00 |
$0.00 |
$0.00 |
$59,000.00 |
| Depreciation &
Amortization |
$21.40 M
|
$11.03 M
|
$10.94 M
|
$6.42 M
|
$1.07 M
|
| EBITDA |
-$59.28 M
|
-$57.74 M
|
-$40.12 M
|
-$27.85 M
|
-$18.12 M
|
| EBITDA Ratio |
-2.82 |
-2.13 |
-1.91 |
-1.44 |
-1.43 |
| Operating Income Ratio
|
-3.84
|
-2.54
|
-2.43
|
-1.77
|
-1.61
|
| Total Other
Income/Expenses Net |
$1.22 M
|
$28,000.00
|
$537,000.00
|
$2.06 M
|
$1.15 M
|
| Income Before Tax |
-$79.46 M |
-$68.74 M |
-$50.52 M |
-$32.20 M |
-$19.25 M |
| Income Before Tax Ratio
|
-3.78
|
-2.54
|
-2.41
|
-1.67
|
-1.52
|
| Income Tax Expense |
-$1.22 M |
-$36,000.00 |
-$550,000.00 |
-$7,000.00 |
$1.21 M |
| Net Income |
-$78.24 M |
-$68.71 M |
-$49.97 M |
-$32.20 M |
-$19.25 M |
| Net Income Ratio |
-3.72 |
-2.54 |
-2.38 |
-1.67 |
-1.52 |
| EPS |
-2.72 |
-2.49 |
-9.25 |
-1.8 |
-1.34 |
| EPS Diluted |
-2.72 |
-2.49 |
-9.25 |
-1.8 |
-1.34 |
| Weighted Average Shares
Out |
$28.81 M
|
$27.58 M
|
$5.40 M
|
$17.92 M
|
$14.41 M
|
| Weighted Average Shares
Out Diluted |
$28.81 M
|
$27.58 M
|
$5.40 M
|
$17.92 M
|
$14.41 M
|
| Link |
|
|
|
|
|
